"Indinavir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
| Descriptor ID |
D019469
|
| MeSH Number(s) |
D03.383.725.385
|
| Concept/Terms |
L-735 524- L-735 524
- L 735 524
- L735 524
- L-735,524
- L 735,524
- L735,524
|
Below are MeSH descriptors whose meaning is more general than "Indinavir".
Below are MeSH descriptors whose meaning is more specific than "Indinavir".
This graph shows the total number of publications written about "Indinavir" by people in this website by year, and whether "Indinavir" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Indinavir" by people in Profiles.
-
Pairwise additivity of energy components in protein-ligand binding: the HIV II protease-Indinavir case. J Chem Phys. 2011 Aug 28; 135(8):085101.
-
Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India. J Int Assoc Physicians AIDS Care (Chic). 2011 Mar-Apr; 10(2):111-8.
-
The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS. 2008 Sep 12; 22(14):1799-807.
-
Effects of 5 HIV protease inhibitors on vasomotor function and superoxide anion production in porcine coronary arteries. J Acquir Immune Defic Syndr. 2005 Sep 01; 40(1):12-9.
-
Virological and immunological outcomes in HIV-1-infected Chinese patients treated with a combination of Efavirenz and Indinavir for 48 weeks. Chin Med J (Engl). 2004 Mar; 117(3):347-52.
-
A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). AIDS. 2000 Jul 28; 14(11):1591-600.
-
The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome. Int J STD AIDS. 2000 Apr; 11(4):220-3.
-
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy. Antimicrob Agents Chemother. 2000 Apr; 44(4):1029-34.
-
Gynecomastia associated with indinavir therapy. Clin Infect Dis. 1998 Dec; 27(6):1539-40.
-
A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus. J Pediatr. 1998 Mar; 132(3 Pt 1):543-6.